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Abstract. The effects of acute and chronic chlorpromazine treatment on psy- 
chomotor stimulant self-administration behavior in the Rhesus monkey were 
determined. Chlorpromazine treatment significantly increased the frequency of 
self-administration of cocaine, pipradrol, phenmetrazine, d-amphetamine and 
methyIphenidate. The basis of this effect was thought to either be due to an anta- 
gonism of the reinforcing effect of these compounds or an antagonism of those 
actions of the psychomotor stimulants which may function in limiting their self- 
administration. 
Key words: Self-Administration--Cocaine--Chlorpromazine--Phenmetrazine-- 
Methylphenidate. 
The relationships between response rate and magnitude of rein- 
forcement and between magnitude of reinforcement and total drug 
intake have been studied in rats and in monkeys which self-administered 
various psychomotor stimulants (Pickens et al., 1967 ; Pickens and Harris, 
1968; Deneau and Inoki, 1967; and Wilson et al., 1971). These investi- 
gators found that  an inverse relationship existed between infusion dosage, 
i.e., magnitude of reinforcement and frequency of self-administration. 
Furthermore, total daily drug intake was independent of infusion 
dosage over a wide range of dosages. 
These results indicate that  either a direct effect of the drug being 
self-administered or some central mechanism is ftme$ioning to limit 
drug intake. In  either case, one should be able to produce changes in 
drug intake by treatment with other compounds. These treatment drugs 
may either potentiate or block effects of psychomotor stimulants or 
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interact in some manner with a central regulating mechanism which may 
function in limiting drug intake. 
The present study was designed to determine ff t reatment with 
chlorpromazinc, which has been shown to antagonize many behavioral and 
physiological effects of the psychomotor stimulants, would significantly 
alter the amount of these compounds which would be serf-administered. 
Method 
The subjects were eight adult Rhesus monkeys, weighing between 4.2 
and 5.5 kg. They were permanently housed in individual open-faced 
experimental cubicles which have been previously described (Wilson et al., 
1971). Each cubicle contained a stimulus light and lever. Subject restraint 
was accomplished by a stainless steel arm and harness which permitted 
relatively free movement (u et al., 1965). After each subject had 
adapted to this environmental situation for seven days, he was prepared 
with a chronic indwelling jugular catheter (Wilson et al., 1971). 
When the stimulus light was illuminated, a single depression of the 
lever with at least 100 g of force activated an injection unit. This resulted 
in the intravenous administration of a given volume of drug solution or 
of physiologic saline. 
Following catheter implantation, each subject was returned to his 
cubicle and the stimulus light was illuminated twenty-four hours a day 
for seven days. Each lever-press made during this period resulted in the 
administration of 0.2 cc/kg of sterile physiologic saline. During an injec- 
tion cycle, which lasted 45--60 see depending on subject weight, the 
stimulus light was turned off and lever presses had no consequence. 
Each subject's lever-pressing frequency for saline was determined during 
this period and this value served as a control. 
Following this seven day period, the saline was replaced with a 1.0 mg/ec 
solution of cocaine hydrochloride in sterile physiologic saline. Initially, 
the subjects had unlimited access to the cocaine and each lever-press 
resulted in the administration of 0.2 mg/kg of cocaine hydrochloride. New 
solutions were prepared every two days and the old solutions were dis- 
carded. Once a subject had initiated increased self-administration beha- 
vior as compared to tha t  observed with saline, the drug access period 
was reduced from twenty-four to four hours daily. This was done to 
reduce the neurotoxic effects of cocaine which develop within five to 
seven days ff subjects are allowed unlimited access to cocaine. Further- 
more, this limited access schedule resulted in stable ( •  10e/0) daily 
cocaine intake. The drug access period, which was from 11:00 a.m. to 
3:00p.m.,  was indicated by the illumination of the stimulus light. 
During the period between sessions, lever presses were recorded but  had 
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no consequence. Each subject self-administered cocaine under these 
limited access conditions for three weeks. 
At this time, the schedule of reinforcement was changed for four of 
the eight subjects. Two of the subjects were required to press the lever ten 
times before they received an injection of cocaine; twenty-five responses 
were required for the other two subjects. Therefore, four subjects were on 
FR-1, two on FR-10, and two on FR-25 schedule of reinforcement. 
The amount  of cocaine received per injection was 0.2 mg/kg in all 
subjects except those on the FR-25 schedule of reinforcement. In  these 
subjects the unit  dosage was 0.1 mg/kg per injection. Furthermore,  the 
drug access period was reduced to two hours in those subjects on the FR- 
10 and FR-25 schedules of reinforcement. The subjects on the FLY-10 and 
FR-25 schedules of reinforcement were run for an additional two weeks 
until daffy drug intake had stabilized. Pre t rea tment  studies were begun 
in the other four subjects during this time. Both acute and chronic 
chlorpromazine pret reatment  studies were conducted inthe subjects onthe 
Fl%-I schedule of reinforcement; however, only acute pretreatment  
experiments were conducted in the subjects on the FR-10 and FR-25 
schedules. 
a) Acute Pretreatment (Cocaine). Six different dosages of ehlorprom- 
azine ranging from 0.125 to 8.0 mg/kg were studied in each of the eight 
subjects and each dosage was tested once in each subject. The chlor- 
promazine was dissolved in sterile physiologic saline and all solutions were 
prepared on the day on which they were to be administered. The solutions 
were administered intramuscularly five minutes prior to the onset of the 
drug access period. The volume of the pret reatment  injection was 1.0 cc, 
and this was held constant throughout the study. 
b) Chronic Pretreatment (Cocaine). Following completion of the acute 
pre t rea tment  s tudy in those subjects on the FR-1 schedule of reinforce- 
ment,  a dosage of chlorpromazine which had significantly increased the 
frequency of cocaine self-administration behavior in the acute s tudy 
(2.0 mg/kg), was administered intramuscularly to four subjects, five 
minutes before the s tar t  of the daily session for five consecutive days. 
This was done to determine ff tolerance would develop rapidly to this 
effect of chlorpromazine. Saline control pre t reatment  sessions were 
conducted immediately before and after the chronic t rea tment  regimen in 
each subject. 
c) Acute Pretreatment (Other Psychomotor Stimulants). Following the 
determination of the effects of acute and chronic chlorpromazine pre- 
t rea tment  on cocaine self-administration behavior, all subjects were re- 
turned to a FR-1 schedule of reinforcement for three days. At this time, 
the cocaine was replaced with a solution of methylphenidate hydrochloride 
in sterile saline in four of the eight subjects, and a solution of pipradrol 
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hydrochloride in the remaining four subjects. Each of these subjects 
self-administered these compounds for fourteen days. Those self-admini- 
stering methylphenidate received 0.05 mg/kg/injection; whereas, those 
self-administering pipradrol received 0.0t mg/kg/injection. Stable base- 
lines of daily drug intake were ascertained during this period. Seven 
pre-treatment dosages of chlorpromazine, ranging from 0.125 to 8.0 mg/kg 
were administered to each of the eight subjects. The pretreatment volume 
was again held constant at 1.0 cc and pretreatment solutions were 
prepared using sterile physiologic saline on the day in which they were 
to be used. Pretreatment dosages were administered intramuscularly 
five minutes before the onset of the drug access period and at least 
three days elapsed between pretreatment sessions. ~ive control pre- 
treatment sessions, i.e., intramuscular injection of 1.0 cc of sterile 
physiologic saline, were again conducted in each subject. 
After the control sessions and chlorpromazine pretreatment sessions 
had been conducted in these subjects, the psychomotor stimulants being 
self-admlnistered were again changed. Phenmetrazine hydrochloride, 
0.1 mg/kg/injection, was substituted for methylphenidate and d-amphet- 
amine sulfate, 0.025 mg/kg/injeetion, was substituted for the pipradrol. 
The drug pretreatment procedure was repeated in the eight subjects. 
Following stabilization of total drug intake within fourteen days, each 
subject was pretreated with at least four dosages of ehlorpromazine and 
with five injections of saline. 
Results 
a) Acute Pretreatment (Cocaine). Fig. 1 illustrates the mean percentage 
change in cocaine self-administration as a function of the pretreatment 
dosage of chlorpromazine (CPZ). The points represent the mean values 
obtained from four subjects and the vertical lines indicate the range. The 
brackets at the left represent the range for twenty saline control pre- 
treatment sessions, five conducted in each subject. CPZ in dosages of 
0.125--4.0 mg/kg produced a mean increase (15--55~ in cocaine self- 
administration. When the CPZ pretreatment dosage was increased to 
8.0 mg/kg, there was gross evidence of marked CNS depression and 
catalepsy and cocaine self-administration was significantly depressed. 
Pretreatment dosages (0.25--4.0 mg/kg) of chlorpromazine produced an 
increase in cocaine self-administration during the first, second, and third 
hours of the session. Pretreatment with 8.0 mg/kg of CPZ increased 
cocaine self-administration only during the first hour of the session. This 
dosage depressed all behavior during the second, third and fourth hours. 
During the fourth hour, only pretreatment dosages of 1.0--4.0 mg/kg of 
CPZ were effective in increasing cocaine intake. Cocaine intake had 
returned to control levels with lower pretreatment dosages of CPZ, i.e., 
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0.25 and  0.5 mg/kg by  this t ime. Therefore, both  the magn i tude  a nd  
du ra t ion  of the CPZ induced increase in  cocaine se l f -adminis t ra t ion 
were dose-related up to a point ,  i.e., 8.0 mg/kg. Similar results were 
ob ta ined  with all four subjects  in  this phase of the s tudy.  
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l~ig. 1. Mean percentage change in cocaine self-administration as a function of the 
pretreatment dosage of chlorpromazine. Each point represents the mean of four 
subjects and the vertical lines illustrate the range. The brackets at the left represent 
the range of change in cocaine-self-administration which occurred following 
pretreatmcnt with saline. Five of these control sessions were conducted in each 
subject 
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Fig.2. Cocaine intake as a function of the pretreatment dosage of chlorpromazine 
in two subjects self-administering cocaine. M2143 was on a FR-25 schedule and 
M2161 on a FR-10 schedule of reinforcement. Each point represents total cocaine 
intake for that session in one subject. Vertical lines at the left represent the range 
of cocaine intake which occurred during five control, i.e., saline pretreatment, 
sessions. The superimposed point represents mean cocaine intake for these control 
sessions 
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The effect of acute chlorpromazine p re t r ea tmen t  on cocaine self- 
admin is t ra t ion  in  subjects  on higher fixed rat io schedules of re inforcement  
is i l lustrated in  Fig.2.  CPZ in  dosages of 0.125--2.0 mg/kg increased 
cocaine self-adminis t rat ion in  M 2161, who was on a FR-10  schedule of 
re inforcement  for cocaine a t  a u n i t  dosage of 0.2 mg/kg-injection.  How- 
ever, in  M 2143 who was self-administering cocaine a t  a un i t  dosage of 
0.1 mg/kg on a FR-25  schedule of reinforcement,  only p re t r ea tmen t  
50 F- | ~ No.2161 FR-10 cocaine 0.2mg/kg 
~401--" 50~ = =No.21Z,3FR-25cocaine0.1mg/kg / 
/ 
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Fig. 3. Median latencies (sees.) in two subjects self-administering cocaine on a FR-10 
and ~R-25 schedule of reinforcement as a function of the pretreatment dosage of 
chlorpromazine. The vertical lines and superimposed points at the left indicate the 
range and mean respectively obtained from five control, i.e., saline pretreatment, 
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Fig.4. Median nmning rates (responses per see) in two subjects self-administering 
cocaine on a FR-10 and FR-25 schedule of reinforcement as a function of the 
pretreatment dosage of chlorpromazine. The vertical lines and superimposed points 
at the left indicate the range and mean respectively, obtained from five control, 
i.e., saline pretreatment, sessions conducted in each subject 
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dosages of 1.0 and 2.0 mg/kg were effective in increasing cocaine sel l  
administration, l~ with 4.0 mg/kg CPZ almost completely 
suppressed cocaine reinforced behavior in both subjects. At this dosage, 
the subjects exhibited marked CNS depression and catalepsy which was 
quantitatively similar to that  produced by the 8.0 mg/kg dose of CPZ in 
subjects self-administering cocaine on a FR-1 schedule of reinforcement. 
Figs. 3 and 4 illustrate the effects of CPZ pretreatment on median 
latencies and median running rates respectively in these same two 
subjects. Median running rate, i.e., rate of responding from the first 
response to the Nth response on a FR-N schedule of reinforcement, was 
increased two to three times above that  seen during control sessions in 
M 2143 following pretreatment with 0.125--2.0 mg/kg of CPZ. A qualita- 
t ively similar effect was observed in M 2161 when pretreated with 0.25 mg/ 
kg of CPZ. Median running rates were greatly reduced in both subjects 
when the pretreatment dosage was increased to 4.0 mg/kg. Median 
latencies, i.e., time from the last reinforcement or injection to emission of 
the first appropriate response, decreased on both subjects as the pretreat- 
ment dosage was increased from 0.5 to 2.0 mg/kg. Further  increases in 
pretreatment dosage increased latencies. I t  appears then that  both the 
ability of CPZ to decrease latencies of responding for this reinforcer and 
its ability to increase running rates were involved in increasing selL 
administration behavior. 
b) Chronic Pretreatment (Cocaine). ~ig.5 illustrates the effects of 
chlorpromazine chronically administered for 5 days, at a dosage of 
2.0 mg/kg in two subjects which were self-administering cocaine at  a 
unit dosage of 0.2 mg/kg/injection on a FIr schedule of reinforcement. 
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Fig. 5. Percentage change in cocaine self-administration during chronic pretreatment 
with 2.0 mg/kg chlorpromazine 
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Chlorpromazine increased cocaine self-administration on all five days in 
M 2121 and on four of the five days in M 2068. The magnitude of this 
effect was very similar on each of the days in both subjects. Since the 
magnitude of the increase in cocaine intake remained constant throughout 
the period of chronic CPZ treatment,  there was no evidence of tolerance 
developing to this action ofCPZ. On the third day of t reatment in M 2068, 
a very large decrement in cocaine self-administration occurred and 
there was profound evidence of general CNS depression. In  both sub- 
jects, cocaine intake significantly returned toward baseline levels on the 
day following cessation of CPZ treatment. More importantly, this session 
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Fig.& Mean percentage change in phenmetrazine and methylphenidate self- 
administration (upper graph) and pipradrol and d-amphetamine self-administratioa 
(lower graph) as a function of the pretreatment dosage of chlorpromazine. Each 
point represents the mean of four subjects and the vertical lines illustrate the range. 
The brackets at the left indicate the range of change in psychomotor stimulant 
self-administration which occurred following pretreatment with saline. Five of 
these control sessions were conducted in each of four subjects during the period 
in which they self-administered each psychomotor stimulant 
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evidence tha t  the CPZ-induced increase in cocaine intake had been 
conditioned. The slight increase in responding above control levels in 
both subjects on the first day following chlorpromazine pretreatmen~ 
m a y  have been due to the presence of CPZ which had not yet  been 
metabolized and excreted. 
c) Acute Pretreatment (Other Psychomotor Stimulants). Fig.6 illus- 
t rates tha t  acute pretreatment  with chlorpromazine increased methyl-  
phenidate, phcnmetrazine, pipradrol and d-amphetamine self-administra- 
tion behavior. Table 1 reflects the number  of subjects which serf- 
administered the various psychomotor stimulants at  an increased fre- 
quency following pret reatment  with various dosages of chlorpromazine. 
Chlorpromazine in dosages of 0.25--1.0 mg/kg increased phenmetrazine 
intake. However, increases were not observed in all subjects with all 
pre t rca tment  dosages. As the pre t rea tment  dosage was increased from 
0.25-- 1.0 mg/kg, variability in this effect increased. This was apparent ly 
due to intersubject sensitivity to the general CNS depressant effects of  
CPZ. Fur ther  increases in CPZ pret reatment  dosage above 1.0 mg/kg 
decreased phenmetrazine self-administration in the majori ty of subjects. 
The subjects at  these dosages exhibited catalepsy and marked CNS 
depression. 
Pre t rea tment  with 0.5 and 1.0 mg/kg of CPZ increased methylpheni- 
date self-administration. Lower dosages increased this behavior in some of  
the subjects; however, no effect was observed following pret reatment  
with 0.125 mg/kg of CPZ. Pre t rea tment  with 2.0, 4.0, and 8.0 mg/kg of  
CPZ produced a dose-related depression in methylphenidate self-admin- 
istration in all subjects. At these dosages, the subjects exhibited extrem~ 
motor  incapacitation. 
Table 1. Number o] subjects in which chlorpromazine pretreatment increased psy- 




Psychomotor stimulant self-administered 
Cocaine Methyl- Phen Piprach'ol d-amphet- 
phenidate metrazine amine 
0.125 3 (4) 0 (4) 1 (4) 0 (4) 1 (4) 
0.25 3 (4) 2 (4) 4 (4) 1 (4) 4 (4) 
0.5 4 (4) 3 (4) a (4) 3 (4) 2 (4) 
1.0 4 (4) 3 (4) 2 (4) 4 (4) 0 (4) 
2.0 4 (4) o (~) ~ (4) 4 (4) - 
4.0 4 (4) 0 (4) - 4 (4) - 
s.o o (4) o (4) - o (4) - 
(--) ~ no subjects tested with this pretreatment dosage. 
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Pretreatment with 0.125 mg/kg of CPZ had no effect on d-amphet- 
amine self-administration behavior; however, dosages of 0.25 and 0.5 mg/ 
kg increased d-amphetamine intake in the majority of the subjects. 
Pretreatment with 1.0 mg/kg of CPZ severely depressed d-amphetamine 
self-administration in all subjects. 
Pretreatment with 0.125 and 0.25 mg/kg of CPZ had no effect on 
pipradrol self-administration. However, pretreatment with 0.5, 1.0, 2.0 
and 4.0 mg/kg increased pipradrol self-administration in a dose-related 
manner. Further increases in pretreatment dosage decreased drug intake 
below control levels. 
Discussion 
The effect of chlorpromazine pretreatment in animals self-administer- 
ing cocaine is indeed significant. CPZ in the dosages which increased serf- 
administration behavior produces a dose-related depression in lever- 
response frequency for other reinforcers, e.g., food, water and social 
reinforcement in this species (unpublished observations from this labora- 
tory). Thus, the increased lever-pressing frequency for psychomotor 
stimulants following CPZ pretreatment may be uniquely related to the 
nature of this reinforcer, i.e., psychomotor stimulant administration. This 
effect on psychomotor stimulant self-administration behavior may or 
may not be related to the schedule of reinforcement. Cocaine intake was 
increased in subjects on FR-1, FR-10 and FR-25 schedules, however, 
only fixed ratio schedules of reinforcement were studied in these experi- 
ments. The dose of CPZ required to produce grossly observable severe 
CNS depression appeared to be inversely related to the value of the FR 
schedule employed. One perhaps could hypothesize that  with the larger 
ratio requirements, more time was needed to self-administer a sufficient 
amount of cocaine to counteract the depressant effects of a given dosage 
of CPZ. 
Increases in the frequency of cocaine self-administration may have 
resulted from the ability of CPZ to antagonize the reinforcing property 
of cocaine. Wilson et al. have previously demonstrated that  decreases in 
the unit dosage, i.e., dosage per injection, of cocaine resulted in an in- 
crease in self-administration frequency over a wide range of reinforcing 
dosages. I f  CPZ antagonized the reinforcing property of cocaine, then 
one would expect to see similar increases in cocaine self-administration 
frequency. 
One could also interpret the results of this study to have occurred 
due to an antagonism of those effects of cocaine which may be involved in 
limiting its serf-administration, e.g. aversiveness or behavioral disruption. 
The work of Piekens and Thompson suggests that  a primary factor 
controlling the rate of responding on fixed ratio schedules of cocaine 
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reinforcement is the length of post reinforcement pause of ongoing 
behavior. Results from the present study indicate that chlorpromazine 
decreases this post reinforcement pause,i.e., decreases the latency follow- 
ing each cocaine injection. This effect in itself would produce an increase 
in cocaine self-administration behavior. 
The work of Stein and Ray provides data which suggests that CPZ 
may be increasing cocaine self-administration by both of these mechanisms. 
These investigators studied the effects of CPZ on intracranial serf- 
stimulation in rats. The subjects were presented with two levers; the 
depression of one led to electrical stimulation of a "reward" area. 
However, the shock intensity decreased progressively with each lever 
press, but could be reset to its original level by a single response on the 
other lever. Apparently the reward threshold was increased by CPZ 
treatment, i.e., CPZ antagolfized the reinforcing effects of the intra- 
cranial stimulation. In addition, the subjects pressed the primary 
reinforcing lever more frequently. These authors postulated that this 
effect resulted from the ability of CPZ to antagonize the after-effects, i.e., 
aversiveness or behavioral disruption, of the brain shock. 
In addition to cocaine, chlorpromazine pretreatment increased the 
frequency of self-administration of other psychomotor stimulants which 
are self-administered by the Rhesus monkey. As the pretreatment dosage 
of CPZ is increased beyond a point, an inverse relationship between 
pretreatment dosage and self-administration behavior is exhibited. The 
point at which this function becomes inverse rather than direct may be 
indicative of the ability of a given psychomotor stimulant to antagonize 
the behavioral depressant properties of CPZ. Therefore, it appears that 
chlorpromazine has the ability to antagonize the effect, common to all 
of the psychomotor stimulants, which determines the amount of these 
compounds which are self-administered. Wilson et al., have demonstrated 
that there is some mechanism which functions to regulate the quantity of 
these compounds which are self-administered. 
There are many references in the literature which demonstrate the 
ability of CPZ to antagonize certain effects of the psychomotor stimulants 
(Rein; Maickel; Espelin and Done; Benesova and Trinerova). This 
further suggests that the increase in psychomotor stimulant self-adminis- 
tration seen following pretreatment with CPZ is due to the ability of 
CPZ to antagonize those actions of the psychomotor stimulants which 
function in regulating their serf-administration. 
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